BeiGene, Ltd. (688235) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

688235 BeiGene, Ltd.

Watchlist

163.20
+2.55+1.59%

Market Closed Jan 13 15:00 CST

226.09BMarket Cap-34.66P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BeiGene Projects Positive Operating Income by 2025
TipRanks8minutes ago
BEIGENE (06160) expects to achieve positive operating profit for the entire year of 2025.
BEIGENE (06160) announced that, according to Generally Accepted Accounting Principles in the USA, the company expects to achieve its full year Operation in 2025...
Zhitong Finance12minutes ago
Express News | Beigene Ltd - Expects to Achieve Positive Operating Income for Full Year 2025
Reuters13minutes ago
Express News | JPMorgan Chase & Co's Long Position in Beigene Decreases to 9.83% on Jan 3 From 10.33% - HKEX
ReutersJan 9 04:14 ET
Beigene Insider Sold Shares Worth $7,370,515, According to a Recent SEC Filing
MT NewswiresJan 8 17:14 ET
Indaptus Therapeutics Provides 2025 Outlook, Launching Decoy20 Combination Cohort With BeiGene's Tislelizumab, Expanding Clinical Sites Beyond 8, Updating Higher Dose Cohort, First Patient Dosed In Combination, Focus On Cancer Challenges
BenzingaJan 8 08:17 ET

Comments

EvaHuang

Nov 12, 2024 06:46

Seems the stock is forgotten by the market

$BEIGENE (06160.HK)$

AlanYeo

Feb 7, 2024 03:18

CIMB: Healthcare Overall – Overweight

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
alphaedgeinvest...
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

AlanYeo

Jan 23, 2024 20:22

China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70 - Alpha Edge Investing
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

Spinee

Jan 17, 2024 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

AlanYeo

Aug 30, 2022 04:23

DBS: China Healthcare Sector – Pharmaceutical Packaging

https://alphaedgeinvesting.com/2022/08/30/dbs-china-healthcare-sector-pharmaceutical-packaging/
$MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $CSPC PHARMA (01093.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

Heat List

Overall

No Data

Investment Theme

Innovative Drugs

Intraday+0.62%

Monoclonal Antibody Concept

Intraday+0.52%